The epigenetic regulation of paraoxonase 1 (PON1) as an important enzyme in HDL function: The missing link between environmental and genetic regulation
- 1 November 2019
- journal article
- review article
- Published by Elsevier in Clinical Biochemistry
- Vol. 73, 1-10
Abstract
No abstract availableKeywords
This publication has 107 references indexed in Scilit:
- Role of microRNAs in diabetes and its cardiovascular complicationsCardiovascular Research, 2011
- Air pollution and circulating biomarkers of oxidative stressAir Quality, Atmosphere & Health, 2010
- The Genetics of Vascular Complications in Diabetes MellitusCardiology Clinics, 2010
- Epigenetics and cardiovascular diseaseNature Reviews Cardiology, 2010
- Atherosclerosis risk factors can impose aberrant DNA methylation patterns: a tale of traffic and homocysteineCurrent Opinion in Lipidology, 2009
- Epigenetics and atherosclerosisBiochimica et Biophysica Acta (BBA) - General Subjects, 2009
- Validation of PON1 enzyme activity assays for longitudinal studiesClinica Chimica Acta, 2009
- Engineered recombinant human paraoxonase 1 (rHuPON1) purified fromEscherichia coliprotects against organophosphate poisoningProceedings of the National Academy of Sciences, 2008
- Paraoxonase 1 gene transfer lowers vascular oxidative stress and improves vasomotor function in apolipoprotein E‐deficient mice with pre‐existing atherosclerosisBritish Journal of Pharmacology, 2008
- Phenotypic plasticity and the epigenetics of human diseaseNature, 2007